Latest News about BIIB
Recent news which mentions BIIB
These Analysts Revise Their Forecasts On Biogen After Q3 Results
November 09, 2023
Tickers
BIIB
From Benzinga
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
November 08, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 08, 2023
From Benzinga
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
November 08, 2023
From Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
November 08, 2023
From MarketWatch
Just turned 50? Here’s where Howard Marks suggests investing for the next 10 years.
November 08, 2023
From MarketWatch
3 Biotech Moonshots to Bet on the Future of Health
November 06, 2023
From InvestorPlace
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
From MarketWatch
From MarketWatch
From MarketWatch
Biogen Says New Data Shows Promise For Potential New Generation Of Treatments In Early Alzheimer's Disease
October 25, 2023
Tickers
BIIB
From Benzinga
Stocks to own ahead of a rally that this $15 billion fund house says is coming soon
October 25, 2023
From MarketWatch
An Oversold Small Cap Industrial That Insiders Are Buying Ahead Of Earnings This Week
October 24, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 23, 2023
From Benzinga
$1000 Invested In Biogen 20 Years Ago Would Be Worth This Much Today
October 18, 2023
Tickers
BIIB
From Benzinga
3 Struggling Stocks Investors Shouldn't Buy on the Dip
October 18, 2023
From Motley Fool
Quant Ratings Updated on 92 Stocks
October 17, 2023
From InvestorPlace
Inquiry Into Biogen's Competitor Dynamics In Biotechnology Industry
October 16, 2023
Tickers
BIIB
From Benzinga
From Benzinga
7 Low-Volatility Stocks to Buy if You’re a Concerned Investor
October 11, 2023
From InvestorPlace
From Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
From Benzinga
An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8
October 05, 2023
From Benzinga
Quant Ratings Updated on 74 Stocks
October 03, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.